why choose us

First received: December 07, 2023

Clinical Trial: Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Adult Ovarian Granulosa Cell Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination With Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor

Brief Summary: This phase II trial tests how well darolutamide in combination with leuprolide acetate and exemestane works in treating patients with ovarian granulosa cell tumors that have come back after a period of improvement (recurrent).Darolutamide is in a class of medications called androgen receptor inhibitors.It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of tumor cells.Leuprolide acetate is in a class of medications called gonadotropin-releasing hormone…

Read more